(Q45085693)

English

Under-recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular function

scientific article published on 29 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Under-recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular function (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

8

object named as

Peter Hillmen

0 references

Stephen J Richards

object named as

Stephen J Richards

5

0 references

Robert J Sapsford

2

object named as

Robert J Sapsford

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

Anita Hill

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Richard Kelly

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Gus Khurisgara

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Mohan U Sivananthan

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

0 references

publication date

29 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

158

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

409-414

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Cardiac involvement in thalassemia intermedia: a multicenter study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Pulmonary hypertension and nitric oxide depletion in sickle cell disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Natural history of paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Biological activity of nitric oxide in the plasmatic compartment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09166.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2012.09166.X

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45085693&oldid=2065479459"